On February 10, 2010
Sanofi Says Heart Drug Multaq Is “on Track”; Numbers Suggest It’s Derailed
Sanofi-Aventis (SNY) claims the launch of its new heart drug Multaq is “on track,” but its own numbers seem to indicate the drug has already been derailed just months into the “blockbuster’s” career.
No tags for this post.
0 Comments